HUNTINGTON, W.Va.--(BUSINESS WIRE)--Vandalia Research has been awarded a $1.04M contract with the US Department of Defense, titled, “Flu Vaccine Technology Program”. This program will focus on the scale-up and pre-clinical development of a pandemic flu vaccine manufactured by Vandalia’s proprietary large scale PCR process using the Triathlon™ bioreactor. The contract is scheduled to run for 18 months and will be performed in collaboration with Dr. Richard Heller of the Frank Reidy Research Center for Bioelectrics at Old Dominion University in Norfolk, Virginia and Dr. Colleen Jonsson, Director, Center for Predictive Medicine at the University of Louisville.
